COVID-19
Not recruitingStudy of GS-5245 for Treating COVID-19 in Children and Adolescents
Study of GS-5245 for Treating COVID-19 in Children and Adolescents
Spain- Participants:0–17 years
- Substances:GS-5245
- Sponsor:Gilead Sciences Inc.
Rare diseases
Investigational molecules
Locations
Back to Spain3 275 clinical trials in Majadahonda, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of GS-5245 for Treating COVID-19 in Children and Adolescents
SpainStudy Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer
SpainStudy of Adagrasib Dosing in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation
SpainStudy Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer
SpainStudy on Brentuximab Vedotin and Drug Combination for Patients with Peripheral T-cell Lymphoma with Less Than 10% CD30 Expression
SpainStudy on the Effectiveness and Safety of SAR441566 for Adults with Moderate to Severe Plaque Psoriasis
SpainStudy of JDQ443 and Ribociclib in Combination for Adult Patients with Advanced Solid Tumors with KRAS G12C Mutation
SpainStudy on the Effectiveness and Safety of Eneboparatide, Calcitriol, and Calcium Carbonate for Patients with Chronic Hypoparathyroidism
SpainStudy of Acalabrutinib, Venetoclax, and Rituximab for Patients with Newly Diagnosed Mantle Cell Lymphoma
SpainStudy on the Effectiveness and Safety of Autogene Cevumeran, Atezolizumab, and mFOLFIRINOX in Patients with Resected Pancreatic Cancer
SpainStudy on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors
SpainStudy of Pembrolizumab, MK-4830, and Chemotherapy for Patients with High-Grade Serous Ovarian Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on ATTR amyloid cardiomyopathy, evaluating new therapeutic approaches for both hereditary and wild-type variants of this heart condition.
Multiple trials testing novel compounds to improve patient outcomes and quality of life.
Comprehensive vaccine development programs targeting urinary tract infections and various herpes virus strains, including studies on both prevention and treatment.
Focus on long-term efficacy and immune response in different age groups.
Advanced research in multiple cancer types, including prostate cancer, gastric cancer, and lymphomas, with emphasis on targeted therapies and combination treatments.
Investigating breakthrough treatments for various stages of cancer progression.
Pioneering research in cerebral ischemic stroke and multiple sclerosis, evaluating innovative treatments to improve patient outcomes and disease management.
Focus on both acute interventions and long-term disease modification.
Tell us about your condition – we search every trial in Europe and connect you with the right site.